Latest Advances

  • Condition: Hepatocellular Carcinoma with Child-Pugh B Cirrhosis
  • Journal: The British journal of surgery
  • Treatment Used: Laparoscopic and Open Liver Resection for Hepatocellular Carcinoma
  • Number of Patients: 382
  • Published —
The study compared the outcomes between Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis.
  • Condition: Hepatocellular Carcinoma (HCC)
  • Journal: Current oncology (Toronto, Ont.)
  • Treatment Used: Sorafenib and Lenvatinib
  • Number of Patients: 0
  • Published —
This article discusses the use of lenvatinib and sorafenib in the first-line management of patients with hepatocellular carcinoma (liver cancer; HCC).
  • Condition: Hepatocellular Carcinoma (HCC)
  • Journal: Current oncology (Toronto, Ont.)
  • Treatment Used: Immunotherapy
  • Number of Patients: 0
  • Published —
This article discusses the role of immunotherapy in the treatment of patients with hepatocellular carcinoma (liver cancer; HCC).
  • Condition: Hepatocellular Carcinoma (HCC)
  • Journal: Current oncology (Toronto, Ont.)
  • Treatment Used: Second-Line Systemic Treatment
  • Number of Patients: 0
  • Published —
This article discusses the second-line systemic treatment for patients with hepatocellular carcinoma (liver cancer; HCC).
  • Condition: Hepatocellular Carcinoma (HCC)
  • Journal: Current oncology (Toronto, Ont.)
  • Treatment Used: Second-Line Therapy
  • Number of Patients: 1280
  • Published —
This review of the literature compared the benefits and toxicities between sorafenib and second-line therapy in patients with advanced hepatocellular carcinoma (liver cancer; HCC).
  • Condition: Hepatocellular Carcinoma (HCC)
  • Journal: Current oncology (Toronto, Ont.)
  • Treatment Used: Locoregional Therapies
  • Number of Patients: 0
  • Published —
This article discusses current locoregional therapies (LRTs) in the treatment of patients with hepatocellular carcinoma (liver cancer; HCC).
  • Condition: Peribiliary Hepatocellular Carcinoma
  • Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
  • Treatment Used: Microwave Ablation
  • Number of Patients: 236
  • Published —
The study researched the use of microwave ablation for patients with peribiliary hepatocellular carcinoma.
  • Condition: Cirrhotic Patients with Early Hepatocellular Carcinoma (HCC)
  • Journal: Current oncology (Toronto, Ont.)
  • Treatment Used: Percutaneous Microwave (MWA) vs. Radiofrequency Ablation (RFA)
  • Number of Patients: 251
  • Published —
This study compared the effectiveness of percutaneous microwave ablation (MWA) versus radiofrequency ablation (RFA) in patients with very early or early hepatocellular carcinoma (liver cancer; HCC).
  • Condition: Hepatocellular Carcinoma
  • Journal: PloS one
  • Treatment Used: Yttrium-90 Transarterial Radioembolization
  • Number of Patients: 1439
  • Published —
In this study, researchers evaluated the outcomes of using yttrium-90 transarterial radioembolization for the treatment of non-surgical hepatocellular carcinoma.
  • Condition: Chronic Hepatitis C
  • Journal: Medicina (Kaunas, Lithuania)
  • Treatment Used: Direct-Acting Antiviral Drugs
  • Number of Patients: 0
  • Published —
This study evaluated changes in liver fibrosis and the risk of developing hepatocellular carcinoma after direct-acting antiviral drug therapy in patients with chronic hepatitis C virus infection.
  • Condition: Patients with Cancer Undergoing Surgery
  • Journal: Integrative cancer therapies
  • Treatment Used: Supplemental Branched-Chain Amino Acids
  • Number of Patients: 0
  • Published —
This review of the literature evaluated the safety and effectiveness of branched-chain amino acids (BCAAs) in the treatment of patients with cancer undergoing surgery.
Showing 1-12 of 1258